Your browser doesn't support javascript.
loading
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis.
Rustgi, Sheila D; Oh, Aaron; Yang, Jeong Yun; Kang, Dasol; Wolin, Edward; Kong, Chung Y; Hur, Chin; Kim, Michelle K.
Afiliação
  • Rustgi SD; Henry D. Janowitz Division of Gastroenterology, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1118, New York, NY, 10029-6574, USA.
  • Oh A; Columbia University Irving Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Yang JY; Columbia University Irving Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Kang D; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Wolin E; Department of Internal Medicine, Lincoln Medical Center, Bronx, NY, USA.
  • Kong CY; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hur C; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kim MK; Columbia University Irving Cancer Center, Columbia University Medical Center, New York, NY, USA.
BMC Cancer ; 21(1): 597, 2021 May 24.
Article em En | MEDLINE | ID: mdl-34030646

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Qualidade de Vida / Neoplasias Gástricas / Somatostatina / Custos de Medicamentos / Tumores Neuroendócrinos / Neoplasias Intestinais Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Qualidade de Vida / Neoplasias Gástricas / Somatostatina / Custos de Medicamentos / Tumores Neuroendócrinos / Neoplasias Intestinais Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article